Efficacy of Oral Psyllium in Pediatric Irritable Bowel Syndrome: A Double-Blind Randomized Control Trial.
- 2022-09-22
- RCT · n = 43
- Journal of pediatric gastroenterology and nutrition 76(1)
- Jagadeesh Menon
- Babu Ram Thapa
- Rajni Kumari
- Srikanth Puttaiah Kadyada
- Satyavati Rana
- Sadhna B Lal
- PubMed: 36136861
- DOI: 10.1097/mpg.0000000000003622
- High evidence
- Clinical
43.9% in Group A versus 9.7% in Group B attained remission [IBS-SSS < 75 ( P < 0.0001)].
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes